未登录

N

Naofumi Kagara

osaka university

H指数:24

被引数:2,090

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a prediction model for ctDNA detection (Cir-Predict) in breast cancer

乳腺癌ctDNA检测预测模型 (cir-predict) 的建立

BREAST CANCER RESEARCH AND TREATMENT

IF3

2025-03-010

OAAI

Comparison of click-to-sense assay with frozen section analysis using simulated surgical margins in breast cancer patients

IF2.9

2022-07-013

OAAI

Comparison of the multigene panel test and OncoScan™ for the determination of HER2 amplification in breast cancer

ONCOLOGY REPORTS

IF3.9

2021-08-100

OA

Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer

IF2.9

2021-02-160

PREAI

Sentinel lymph node biopsy after introducing Twirl® breast markers into suspicious lymph nodes in breast cancer patients

IF2.9

2021-01-030

PREAI

Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2020-06-2419

PREAI

Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation

ONCOLOGY REPORTS

IF3.9

2019-10-109

OAAI

Development of recurrence risk score using 95-gene classifier and its application to formalin-fixed paraffin-embedded tissues in ER-positive, HER2-negative and node-negative breast cancer

ONCOLOGY REPORTS

IF3.9

2019-10-079

OAAI

Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer

血管生成拟态与HER2-positive乳腺癌曲妥珠单抗耐药相关

BREAST CANCER RESEARCH

IF5.6

2019-08-0641

OAAI

Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-04-043

PREAI

HRD (homologous recombination deficiency) score and its clinicopathological features in neoadjuvant chemotherapy treated sporadic breast cancers

CANCER RESEARCH

IF16.6

2019-02-150

PRE

Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-01-0316

PREAI

PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer

PAM50预测ER阳性乳腺癌新辅助化疗疗效

BREAST CANCER RESEARCH AND TREATMENT

IF3

2018-10-2546

PREAI

Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients

BREAST CANCER RESEARCH AND TREATMENT

IF3

2018-05-0410

PREAI

Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing

BREAST CANCER RESEARCH AND TREATMENT

IF3

2017-09-1320

PREAI

A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells

BREAST CANCER RESEARCH AND TREATMENT

IF3

2017-07-1233

PREAI

Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing

BREAST CANCER RESEARCH AND TREATMENT

IF3

2017-03-1029

PREAI

Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients

ONCOLOGY REPORTS

IF3.9

2016-08-0429

OAAI

Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2016-04-2547

PREAI

Importance of TGFβ-SMAD3 axis in resistance to anti-HER2 drugs

CANCER RESEARCH

IF16.6

2016-02-150

PRE